Viewing Study NCT05918302


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2025-12-26 @ 3:01 AM
Study NCT ID: NCT05918302
Status: RECRUITING
Last Update Posted: 2025-12-01
First Post: 2023-03-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
Sponsor: Grupo Espanol de Tumores Neuroendocrinos
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module